InductOs
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tibial Fractures
Conditions
Tibial Fractures
Trial Timeline
Sep 1, 2003 → Aug 1, 2008
NCT ID
NCT00161616About InductOs
InductOs is a approved stage product being developed by Pfizer for Tibial Fractures. The current trial status is completed. This product is registered under clinical trial identifier NCT00161616. Target conditions include Tibial Fractures.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00161616 | Approved | Completed |
Competing Products
2 competing products in Tibial Fractures
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| CP-533, 536 + Placebo + CP-533,536 + CP-533,536 + CP-533,536 | Pfizer | Phase 2 | 51 |
| ALLOB | ICON plc. | Phase 2 | 49 |